Rheumatoid arthritis: achievements and unresolved issues
Authors:
Open Access
- 15 May 2019
- journal article
- editorial
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 91 (5) , 4-7
Abstract
Success in a treatment of rheumatoid arthritis (RA), associated with a development of new medications and improving treatment strategies, allows to achieve remission in many patients. Despite this a lot of theoretical and clinical issues remain, including a definition of the term "remission", its characteristics and types as well as approaches to optimal tactics of "symptomatic" and "pathogenetic" drug therapy at different stages of the disease. Use of a such tactics will allow to induce quickly a state of remission and maintain it for a long term. Further research is needed which should be directed to investigation of a heterogeneity of RA pathogenetic mechanisms and to elaboration of approaches to its early diagnosis as well as to improving methods for monitoring a disease activity, biomarkers of efficacy and resistance to therapy, and finally, to developing of a differentiated therapy, including a search for new “therapeutic” targets. Keywords: rheumatoid arthritis, remission, refractoriness, JAK kinase inhibitorsKeywords
This publication has 45 references indexed in Scilit:
- Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceAnnals of the Rheumatic Diseases, 2016
- Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challengesNature Reviews Rheumatology, 2015
- What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature reviewAnnals of the Rheumatic Diseases, 2014
- Subgrouping of Patients With Rheumatoid Arthritis Based on Pain, Fatigue, Inflammation, and Psychosocial FactorsArthritis & Rheumatology, 2014
- Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activityRheumatology International, 2014
- Proposal for a new nomenclature of disease-modifying antirheumatic drugsAnnals of the Rheumatic Diseases, 2014
- Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: A systematic reviewSeminars in Arthritis and Rheumatism, 2013
- Evaluating disease activity in rheumatoid arthritis: Which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAIJoint Bone Spine, 2012
- Chronic widespread pain in the spectrum of rheumatological diseasesBest Practice & Research Clinical Rheumatology, 2011
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trialThe Lancet, 2009